A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
497 Endometrial Hyperplasia: Risk of coexistence and progression to endometrial Carcinoma. Retrospective cohort study
2021
Endometrial cancer
unpublished
Preserved Fulltext
prognostic impact was independent of clinicopathological and molecular factors (adjusted HR 0.32 95%CI 0.14-0.74, p=0.0077). Conclusion* L1CAM identifies tertiary lymphoid structures with germinal centres. Our data suggest a pivotal role of TLS in the risk of recurrence of EC. L1CAM IHC is simple, available across many study cohorts and could be readily implemented as biomarker of TLS in future trials and clinical care.
doi:10.1136/ijgc-2021-esgo.158
fatcat:2avvcanvybbr5ajgtwk7xgw7ze